The latest announcement is out from Centessa Pharmaceuticals (CNTA).
Centessa Pharmaceuticals plc has appointed John Crowley as the new Chief Financial Officer, effective June 10, 2024, with a substantial compensation package including a base salary of $525,000, potential bonuses, and stock options. Concurrently, former CFO Dr. Gregory Weinhoff transitions to become the Chief Business Officer. Crowley brings a wealth of experience from previous senior finance roles in the pharmaceutical industry, ensuring Centessa’s financial leadership remains strong amidst its executive team reshuffle.
See more insights into CNTA stock on TipRanks’ Stock Analysis page.
